Insomnia During Perimenopause and Menopause: Why It Happens and What Helps

You used to be a decent sleeper. Not perfect, maybe, but functional. Now you’re awake at 3 a.m., sheets kicked off, mind churning through tomorrow’s to-do list while your body can’t decide if it’s overheating or just restless. You’ve tried the chamomile tea, the lavender pillow spray, the “no screens before bed” rule. And yet here you are, exhausted during the day and wide awake at night.

If this sounds familiar, you’re in very large company. Sleep difficulties affect 40 to 60% of women during the menopausal transition, making menopause insomnia one of the most common and least discussed symptoms of this stage of life. The good news: this isn’t something you simply have to endure. There are effective, evidence-based approaches that go well beyond sleep hygiene tips, and most women haven’t heard of them yet.

How Common Is Menopause Insomnia?

More common than most people realize. According to data from the U.S. National Health Interview Survey, 56% of perimenopausal women sleep less than seven hours per night, compared to 33% of premenopausal women. That’s a sharp jump, and it’s not subtle in how it feels.

The numbers hold up in longer-term research too. The Study of Women’s Health Across the Nation (SWAN), a 10-year longitudinal study of over 3,300 women, found that insomnia symptoms were present in 31 to 42% of perimenopausal women at any given annual check-in. Symptoms were more prevalent in late perimenopause than early, and up to 26% developed clinical insomnia severe enough to impair daytime functioning. Among premenopausal women, that figure is closer to 13%.

Canadian data tells a consistent story. The Canadian Longitudinal Study on Aging found that postmenopausal women were significantly more likely to meet criteria for sleep-onset insomnia disorder compared to pre- and perimenopausal women. A separate analysis of Canadian health surveys found that women aged 40 to 59 showed a 29% increase in the likelihood of insomnia symptoms over a single decade, a trend the researchers linked partly to the menopausal transition.

These aren’t small numbers. And yet many women are told, implicitly or explicitly, that poor sleep is just part of the deal. It’s common, yes. But common doesn’t mean untreatable.

Why Menopause Disrupts Sleep: The Hormonal Picture

Estrogen, Progesterone, and Your Sleep Architecture

Your body’s sleep system doesn’t operate in isolation from your hormonal system. Estrogen helps regulate body temperature, supports serotonin production (which influences mood and sleep-wake cycles), and plays a role in melatonin synthesis. Progesterone acts as a natural sedative. Its breakdown products bind to GABA receptors in the brain, the same inhibitory system that promotes relaxation and deepens slow-wave sleep. Together, these hormones keep your sleep architecture intact: the cycling between light sleep, deep sleep, and REM sleep that allows you to wake up feeling restored.

During perimenopause, both estrogen and progesterone don’t simply decline in a straight line. They fluctuate erratically, sometimes surging, sometimes dropping. SWAN data found that rising levels of follicle-stimulating hormone (FSH) were closely associated with greater sleep fragmentation, while declining estrogen was linked to difficulty falling and staying asleep. The degree of fluctuation in estrogen, not just the overall decline, may be what predicts sleep disruption most reliably. Your brain’s sleep-regulation systems are trying to hit a moving target.

Elevated cortisol levels, common during the menopausal transition, layer on top of all of this. Cortisol is a wakefulness signal. When it runs high at night, it competes directly with the physiological conditions your body needs for deep, consolidated sleep.

Hot Flashes, Night Sweats, and the Perception Question

Hot flashes and night sweats are often blamed as the primary culprits behind menopause insomnia. They certainly don’t help. But the relationship is more interesting than it first appears.

Research from Johns Hopkins has shown that many women actually wake up just before a hot flash occurs, not because of it. Changes in the brain that trigger the hot flash also appear to trigger the awakening. The sleep disruption and the hot flash may share a common neurological origin rather than one simply causing the other.

There’s a further wrinkle. The STRIDE study, which followed 623 women, found that the presence of hot flashes alone wasn’t significantly associated with sleep disruption. What mattered was whether the hot flashes were perceived as bothersome. When researchers accounted for how much a woman felt her hot flashes interfered with daily life, the direct statistical link between vasomotor symptoms and sleep disturbance disappeared. The distress around hot flashes may drive more of the insomnia than the physiological events themselves.

This doesn’t mean hot flashes aren’t real or aren’t disruptive. Night sweats are genuinely fragmenting. Waking up drenched and needing to change clothes or sheets breaks sleep in a very concrete way. But it suggests that addressing the distress response to these events, and not only the events themselves, matters for recovery.

It’s Not Just Hormones: The “Menopause Puzzle”

If hormones were the whole story, the solution would be straightforward. But insomnia researchers sometimes call menopausal sleep disruption a “puzzle” because so many pieces interlock.

Many women going through perimenopause and menopause are also navigating the “Sandwich Generation” years: caring for aging parents while still supporting children, managing demanding careers, and processing significant life transitions. These stressors alone can fuel insomnia, and when they’re layered on top of hormonal shifts, the effect compounds. Understanding how chronic stress keeps the nervous system on high alert helps explain why so many women feel “tired but wired” at bedtime.

There’s also the circular connection between insomnia and mood. Anxiety and depression both increase during the menopausal transition, and both have a bidirectional relationship with sleep. Poor sleep worsens mood, and low mood makes sleep harder. Add in age-related changes to circadian rhythm and declining melatonin production, and you begin to see why no single factor explains the whole picture.

One more thing: women sometimes report severe sleep disruption while objective sleep measurements show relatively preserved sleep architecture. This mismatch is real and documented. Frequent transitions between sleep states, which hot flashes cause, increase conscious awareness and memory of nighttime waking. Sleep can feel worse than it technically was. That’s not catastrophizing. It’s how perception and physiology interact in this particular context.

Why Sleep Tips Alone Don’t Fix Menopausal Insomnia

Keeping your bedroom cool, avoiding caffeine after noon, and putting your phone away before bed are all reasonable habits. They support good sleep. But they are not treatments for chronic insomnia.

Sleep hygiene is a bit like flossing. It’s a good baseline practice, but if you have a cavity, flossing alone won’t fix it. When insomnia has become chronic, meaning it’s been disrupting your sleep at least three nights per week for three months or more, the problem has usually taken on a life of its own. Habits, thought patterns, and conditioned associations with your bed and bedroom start maintaining the insomnia independently of whatever originally triggered it.

At that point, what’s needed is a structured intervention that directly addresses those maintaining factors. And that’s where most women hit a gap: they’re rarely told that such an intervention exists, is non-pharmacological, and has strong evidence behind it.

What Is CBT-I, and Does It Work for Menopause Insomnia?

Cognitive Behavioural Therapy for Insomnia (CBT-I) is a structured, short-term therapy, typically four to eight sessions, that targets the behaviours, thought patterns, and conditioned responses that keep insomnia going. Its core components include stimulus control (rebuilding the association between your bed and sleep), sleep restriction (temporarily consolidating your sleep window to increase sleep drive), and cognitive restructuring (working with the anxious, frustrated thinking that tends to amplify sleep problems).

The evidence for CBT-I in menopausal insomnia is strong. A 2024 scoping review of randomized controlled trials found that CBT-I significantly improves sleep quality and reduces insomnia severity in menopausal women, with improvements persisting for up to six months after treatment ends. The MS-FLASH study, one of the largest trials to compare interventions for menopausal sleep problems, found that CBT-I outperformed venlafaxine, escitalopram, yoga, aerobic exercise, omega-3 supplements, and estradiol for reducing insomnia severity. The mean reduction in the Insomnia Severity Index for CBT-I was 5.2 points, compared to 2.3 for venlafaxine and 2.1 for exercise.

CBT-I outperformed medication, exercise, and hormonal treatment for the specific problem of insomnia. It’s not that those other approaches don’t have value. They do, particularly HRT for vasomotor symptoms. But for the insomnia itself, CBT-I addresses the maintaining factors that other treatments don’t reach.

CBT-MI: When Insomnia and Hot Flashes Are Both in the Picture

For women dealing with both insomnia and significant vasomotor symptoms, there’s a more targeted variant. Cognitive Behavioural Therapy for Menopausal Insomnia (CBT-MI) combines standard CBT-I with elements drawn from cognitive behavioural therapy for hot flashes. In a randomized controlled pilot trial of 43 women, a four-session CBT-MI protocol produced an average reduction of 10.2 points on the Insomnia Severity Index, compared to 6.2 points in the control group. Sleep self-efficacy, meaning confidence in one’s ability to sleep, also improved significantly and held at one-month follow-up. The protocol directly addresses the perceived interference of hot flashes, which, as the STRIDE data suggests, may be doing as much harm as the flashes themselves.

CBT-I and CBT-MI don’t compete with HRT. They address different pieces of the puzzle. HRT targets the hormonal drivers, while CBT-I targets the behavioural and cognitive patterns that have locked insomnia into place. For many women, the most effective approach involves both. Acceptance and Commitment Therapy techniques, such as defusing from unhelpful thoughts and accepting uncomfortable body sensations rather than fighting them, can also fit naturally alongside CBT-I, particularly for women managing nighttime anxiety and hot flash distress.

A client, a woman in her early 50s, came in convinced her insomnia was entirely about the hot flashes. And they were certainly part of it. But over the course of treatment, she began to see that the anxiety she’d built around sleep, the clock-watching, the early bedtimes to “catch up,” the growing dread as evening approached, were doing as much to maintain her insomnia as the night sweats were. Through CBT-I, she significantly reduced the number of times she woke during the night and found she could get back to sleep much more quickly when she did wake. Her daytime energy and mood improved. She described it as feeling like herself again.

What About Medication and HRT?

Hormone therapy remains the most effective treatment for vasomotor symptoms, and it can also improve sleep. Not all HRT formulations are equal on that front, though. Research suggests that transdermal estradiol combined with oral micronized progesterone offers the most pronounced sleep benefit. The progesterone formulation matters: micronized progesterone works through GABA pathways in ways that synthetic progestins (such as dienogest or norethisterone) do not, and the sleep data reflects that difference. If you’re discussing HRT options with your doctor, asking specifically about the formulation is worthwhile.

For women who can’t take hormone therapy, a newer non-hormonal option has emerged. Fezolinetant (brand name Veozah) is an NK3 receptor antagonist approved for moderate-to-severe vasomotor symptoms. It works by blocking neurokinin B signalling in the hypothalamus, which restores more normal thermoregulatory function. In the 24-week DAYLIGHT trial of 453 women, fezolinetant significantly reduced both vasomotor frequency and sleep disturbance compared to placebo, with sleep improvements appearing as early as the first week of treatment. Objective actigraphy measurements confirmed reductions in wakefulness after sleep onset and improvements in sleep efficiency. It requires liver function monitoring and has some contraindications, so this is a conversation to have with your prescribing physician.

CBT-I is still first-line for the insomnia itself. Medication and hormone therapy address the hormonal and vasomotor picture. For many women, both tracks run in parallel.

Sleep Apnea: The Underdiagnosed Variable

Something that often gets missed in the menopause-insomnia conversation: the risk of obstructive sleep apnea increases substantially after menopause, by some estimates two to three times the premenopausal risk. This is partly hormonal. Progesterone normally acts as a respiratory stimulant, keeping upper airway muscles toned. As it declines, the airway becomes more prone to collapse during sleep.

Sleep apnea in women often doesn’t look like sleep apnea in men. Instead of classic loud snoring and witnessed gasping, women more commonly report chronic fatigue, difficulty staying asleep, morning headaches, and mood changes. Because these symptoms overlap almost entirely with typical menopause complaints, apnea can go undetected for years.

If you’re waking unrefreshed despite spending enough time in bed, noticing morning headaches, or someone has observed you pausing in your breathing, raise sleep apnea with your GP. A referral for a home sleep study is usually straightforward.

When Should You Seek Help?

If your sleep has been consistently disrupted for three months or more and the frustration around it has started to feel like its own problem, those are good signals that it’s time to look beyond lifestyle adjustments. Daytime fatigue, irritability, or difficulty concentrating that traces back to poor sleep belongs in that category too.

What a first CBT-I session actually looks like is less mysterious than most people expect. There’s no homework assigned at the first appointment. It’s mostly a detailed sleep history, a conversation about what’s been going on, and an explanation of how the treatment works. Knowing that can make it easier to take the step.

You Don’t Have to Wait This Out

Menopause insomnia has identifiable causes and responds well to treatment. Not treatment that tries to sleep its way through the hormonal chaos, but treatment that addresses what’s keeping the insomnia going once it’s taken hold. Those are different problems, and CBT-I is built for the second one.

If you’re in British Columbia and your sleep has been off the rails for longer than feels acceptable, book a free consultation and let’s talk about what’s going on and whether CBT-I might be a good fit.